RecruitingPhase 1NCT06578000

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients a Randomised Controlled Trial


Sponsor

NOUR ALI ABO EL ELAA FRAGHLY

Enrollment

40 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is conducted To evaluate the effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis.


Eligibility

Min Age: 20 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Magnesium sulfate and conventional therapy for people with lateral epicondylitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMagnesium sulfate

Iontophoresis therapy (MgO4 will be applied to the active positive electrode and the treatment will be repeated twice a week for four weeks) + conventional therapy (Splint + Stretch + strength).

OTHERconventional therapy

conventional therapy (Splint + Stretch + strength) twice a week for six weeks


Locations(1)

Faculty of Physical Therapy

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06578000


Related Trials